Page last updated: 2024-08-23

amikacin and Infection, Mycobacterium avium-intracellulare

amikacin has been researched along with Infection, Mycobacterium avium-intracellulare in 56 studies

Research

Studies (56)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (3.57)	18.7374
1990's	19 (33.93)	18.2507
2000's	3 (5.36)	29.6817
2010's	9 (16.07)	24.3611
2020's	23 (41.07)	2.80

Authors

Authors	Studies
Chatterjee, A; Daley, CL; Hart, E; Hassan, M; Lesher, B; Obradovic, M; van Ingen, J	1
Kidogawa, M; Nemoto, K; Yamasaki, K; Yatera, K	1
Brode, SK; Carlson, KF; Henkle, E; Ku, JH; Marino, M; Marras, TK; Winthrop, KL	1
He, W; Li, Y; Liu, C; Ma, A; Qiu, Q; Zhao, Y	1
Chen, J; Chen, X; Hua, W; Lin, S; Liu, H; Shao, L; Wang, S; Zhang, W; Zhang, Y	1
Abadi, SSD; Aghababa, AA; Arabpour, E; Bostanghadiri, N; Centis, R; Farahbakhsh, M; Malekshahian, D; Migliori, GB; Nasiri, MJ; Sotgiu, G; Yazarlou, F; Zangiabadian, M	1
Alcaide, F; Andres, S; Aubry, A; Benmansour, H; Boarbi, S; Cambau, E; Chryssanthou, E; Cirillo, DM; Fernström, L; Fitzgibbon, MM; Fröberg, G; Giske, CG; Hyyryläinen, HL; Kahlmeter, G; Keller, PM; Machado, D; Maurer, FP; Mengshoel, AT; Mok, S; Nadarajan, D; Schön, T; Svensson, E; Turnidge, J; van Ingen, J; Viveiros, M; Werngren, J	1
Chong, YP; Jo, KW; Kim, SM; Lee, HJ; Shim, TS	1
Ashizawa, N; Hirayama, T; Hosogaya, N; Ide, S; Ito, Y; Iwanaga, N; Izumikawa, K; Kido, T; Mukae, H; Obase, Y; Okano, S; Ozasa, M; Sakamoto, N; Takao, D; Takazono, T; Takeda, K; Takemoto, S; Tashiro, M; Yanagihara, K	1
Kagawa, T; Kanaoka, K; Kobayashi, T; Kurahara, Y; Maeda, Y; Tachibana, K; Takeuchi, N; Tanaka, Y; Tsuyuguchi, K; Yoshida, S	1
Daley, CL; Nguyen, MH	1
Jo, KW; Kim, MN; Park, B; Shim, TS; Sung, H; Won, EJ	1
Faksri, K; Hinwan, Y; Kaewprasert, O; Sirichoat, A	1
Del Parigi, A; Swenson, C	1
Shulha, J	1
Chang, CL; Chen, LC; Chien, JY; Hsueh, PR; Yu, CJ	1
Brown-Elliott, BA; Ciesielska, M; Codecasa, LR; Coulter, C; Flume, PA; Griffith, DE; Mange, KC; Marras, TK; Morimoto, K; Ruoss, SJ; Thomson, R; van Ingen, J; Wallace, RJ; Winthrop, KL; Yim, JJ; Yuen, DW	1
Nambiar, S; Schumann, K; Walinsky, S	1
Hoy, SM	1
Huh, HJ; Jhun, BW; Kim, DH; Kim, SY; Koh, WJ; Lee, NY; Moon, SM; Shin, SJ; Song, JY	1
Addrizzo-Harris, DJ; Aksamit, TR; Brown-Elliott, BA; Ciesielska, M; Coulter, C; Field, SK; Flume, PA; Griffith, DE; Hoefsloot, W; Mange, KC; Morimoto, K; Thomson, R; van Ingen, J; Wallace, RJ; Winthrop, KL; Yuen, DW	1
Axiotakis, LG; Enver, N; Keating, CL; Pitman, MJ	1
Boeree, MJ; Danho, R; Hoefsloot, W; Kuipers, S; Pennings, LJ; Schildkraut, JA; Svensson, EM; van Ingen, J; Wertheim, HFL; Zweijpfenning, SMH	1
Addrizzo-Harris, DJ; Aksamit, TR; Codecasa, LR; Coulter, C; Eagle, G; Field, SK; Flume, PA; Griffith, DE; Hasegawa, N; Hill, AT; Loebinger, MR; Marras, TK; Morgan, L; Morimoto, K; Nezamis, J; O'Donnell, AE; Philley, JV; Ringshausen, FC; Ruoss, SJ; Thomson, R; van Ingen, J; Wallace, RJ; Winthrop, KL; Yim, JJ	1
Daley, CL; Olivier, KN	1
Aschenbrenner, DS	1
Shirley, M	1
Brown-Elliott, BA; Griffith, DE; Iakhiaeva, E; Stout, JE; Turenne, CY; Wallace, RJ; Wolfe, CR; Woods, GL	1
Bhattacharyya, D; Brewer, CC; Fleshner, M; Folio, LR; Glaser, TS; Holland, SM; Olivier, KN; Park, IK; Prevots, DR; Sampaio, EP; Shallom, S; Shaw, PA; Siegelman, JR; Zalewski, CK; Zelazny, AM	1
Akiyama, M; Betsuyaku, T; Hasegawa, N; Ishii, M; Kohno, M; Namkoong, H; Suzuki, K; Takeuchi, T; Tasaka, S; Yagi, K	1
Eather, GW; Ellender, CM; Law, DB; Thomson, RM	1
Aarnoutse, RE; Boeree, MJ; Daley, CL; Egelund, EF; Heifets, LB; Levin, A; Mouton, JW; Peloquin, CA; Totten, SE; van Ingen, J	1
Forslöw, U; Geborek, A; Heurlin, N; Hjelte, L; Petrini, B	1
Brumble, L; Garland, JL; Johnson, MM; Khoor, A; Roy, A; Waller, EA	1
Davis, KK; Jacobs, SS; Kao, PN; Ruoss, SJ	1
Grosset, J; Ji, B; Lounis, N; Truffot-Pernot, C	1
Fattorini, L; Li, B; Orefici, G; Piersimoni, C; Ricci, ML; Santoro, C; Tortoli, E; Xiao, Y	1
Bermudez, LE; Kolonoski, P; Martinelli, J; Petrofsky, M; Young, LS	1
Castagnola, E; Giacchino, R; Losurdo, G; Olliaro, P; Tasso, L	1
Chan, CY; Cheng, AF; Li, MS; Tam, CM; Yew, WW	1
Jorup-Rönström, C; Julander, I; Petrini, B	1
Coker, RJ; Fisher, M; Tomlinson, DR	1
Chiang, SM; Dorr, RT; Grayson, JB; Hersh, EM; Oka, M; Petersen, EA; Proffitt, RT	1
Barbeau, P; Lapeyre, C; Leng, B; Maugein, J; Pellegrin, I; Pellegrin, JL	1
Clumeck, N; De Wit, S; Payen, MC	1
Koster, F	1
Barber, TW; Currier, J; Ellner, JJ; Hafner, R; Hojczyk, P; Hooton, TM; Jacobs, MR; Limjoco, M; Parenti, DM; Powderly, WG; Simpson, G; van der Horst, C; Williams, PL	1
Horgen, L; Legrand, E; Rastogi, N	1
Caccamo, F; de Lalla, F; Marone, P; Maserati, R; Nicolin, R; Rigoli, R; Scarpellini, P	1
Bartok, AE; Chiu, J; Deresinski, SC; Feigal, DF; Kemper, CA; Leedom, JM; McCutchan, JA; Meng, TC; Nussbaum, J; Tilles, JG	1
Benson, CA; Kessler, HA; Pottage, JC; Trenholme, GM	1
Bermudez, LE; Cogger, J; Lin, JP; Yau-Young, AO; Young, LS	1
Bozzette, S; Chiu, J; Heseltine, PN; Leedom, J; McCutchan, JA; Nussbaum, J; Tilles, JG; Young, LS	1
Inderlied, CB; Kolonoski, PT; Wu, M; Young, LS	1
Cynamon, MH; Ginsberg, RS; Palmer, GS; Swenson, CE	1

Reviews

6 review(s) available for amikacin and Infection, Mycobacterium avium-intracellulare

Article	Year
Nontuberculous mycobacterial lung disease caused by Expert review of respiratory medicine, 2021, Volume: 15, Issue:11 Topics: Amikacin; Cost of Illness; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia	2021
Amikacin liposome and Mycobacterium avium complex: A systematic review. PloS one, 2022, Volume: 17, Issue:12 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Liposomes; Lung Diseases; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies	2022
Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start? Clinics in chest medicine, 2023, Volume: 44, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Lung Diseases; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Treatment Outcome	2023
Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use. Clinical drug investigation, 2021, Volume: 41, Issue:4 Topics: Administration, Inhalation; Adult; Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum	2021
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease. Drugs, 2019, Volume: 79, Issue:5 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Humans; Liposomes; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Treatment Outcome; Young Adult	2019
[Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection]. Revue des maladies respiratoires, 1997, Volume: 14 Suppl 5 Topics: Activities of Daily Living; AIDS-Related Opportunistic Infections; Amikacin; Anemia; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cause of Death; Chemoprevention; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Fever; Granulocyte Colony-Stimulating Factor; Health Status; Humans; Immunocompromised Host; Immunotherapy; Incidence; Interferon-gamma; Molecular Biology; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifabutin; Tuberculosis; Virulence; Weight Loss	1997

Trials

6 trial(s) available for amikacin and Infection, Mycobacterium avium-intracellulare

Article	Year
Amikacin Liposome Inhalation Suspension for Annals of the American Thoracic Society, 2021, Volume: 18, Issue:7 Topics: Administration, Inhalation; Adult; Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Treatment Outcome	2021
Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates. Scientific reports, 2021, 03-17, Volume: 11, Issue:1 Topics: Aged; Amikacin; Drug Resistance, Bacterial; Female; Genotype; Humans; Male; Middle Aged; Mutation; Mycobacterium abscessus; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; RNA, Bacterial; RNA, Ribosomal, 16S	2021
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure. Chest, 2021, Volume: 160, Issue:3 Topics: Administration, Inhalation; Adult; Amikacin; Anti-Bacterial Agents; Bacteriological Techniques; Drug Monitoring; Female; Humans; Liposomes; Long Term Adverse Effects; Lung Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum; Treatment Outcome	2021
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by American journal of respiratory and critical care medicine, 2018, 12-15, Volume: 198, Issue:12 Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Female; Humans; Liposomes; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Treatment Outcome	2018
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team. AIDS (London, England), 1998, Dec-24, Volume: 12, Issue:18 Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Bacteremia; Ciprofloxacin; Clofazimine; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin	1998
Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amikacin; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Clofazimine; Colony Count, Microbial; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin	1992

Other Studies

44 other study(ies) available for amikacin and Infection, Mycobacterium avium-intracellulare

Article	Year
Liposomal Amikacin Inhalation Suspension-induced Pneumonitis. Internal medicine (Tokyo, Japan), 2022, 08-15, Volume: 61, Issue:16 Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia	2022
Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3 Topics: Aged; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Macrolides; Male; Medicare; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifamycins; United States	2023
Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China. Journal of global antimicrobial resistance, 2022, Volume: 31 Topics: Amikacin; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Rifabutin	2022
In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates. BMC microbiology, 2022, 07-08, Volume: 22, Issue:1 Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Clofazimine; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin	2022
Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium abscessus; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria	2023
Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use. Microbiology spectrum, 2023, 06-15, Volume: 11, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Humans; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Streptomycin; Treatment Outcome	2023
A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:8 Topics: Aged; Amikacin; Anti-Bacterial Agents; Female; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Organizing Pneumonia; Pneumonia	2023
Management of dysphonia caused by amikacin liposome inhalation in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023, 08-01, Volume: 27, Issue:11 Topics: Amikacin; Anti-Bacterial Agents; Dysphonia; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection	2023
Evaluating amikacin minimum inhibitory concentration in trailing growth for Mycobacterium avium complex. Tuberculosis (Edinburgh, Scotland), 2023, Volume: 143 Topics: Amikacin; Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis	2023
Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand. PloS one, 2023, Volume: 18, Issue:11 Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phylogeny; Thailand	2023
Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex. Mayo Clinic proceedings, 2020, Volume: 95, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous	2020
In reply-Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex. Mayo Clinic proceedings, 2020, Volume: 95, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous	2020
Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 98 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Taiwan; Young Adult	2020
FDA's Limited Population Pathway for Antibacterial and Antifungal Drugs. Clinical pharmacology and therapeutics, 2021, Volume: 109, Issue:4 Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cross Infection; Drug Approval; Drug Resistance, Microbial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Liposomes; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nitroimidazoles; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sisomicin; United States; United States Food and Drug Administration	2021
Laryngeal Injury Due to Amikacin Inhalation for Refractory Mycobacterium avium Complex Infection. Chest, 2021, Volume: 159, Issue:4 Topics: Administration, Inhalation; Amikacin; Female; Humans; Laryngoscopy; Larynx; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Respiratory Tract Infections	2021
Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease. Chest, 2022, Volume: 161, Issue:2 Topics: Aged; Amikacin; Antitubercular Agents; Azithromycin; Biomarkers; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Stem Cells	2022
ALIS (Amikacin Liposome Inhalation Suspension): The Beginning of a Wonderland? American journal of respiratory and critical care medicine, 2018, 12-15, Volume: 198, Issue:12 Topics: Amikacin; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies	2018
New Antibiotic Approved for Refractory Mycobacterium Avium Complex. The American journal of nursing, 2019, Volume: 119, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Drug Approval; Humans; Liposomes; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic	2019
In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. Journal of clinical microbiology, 2013, Volume: 51, Issue:10 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Point Mutation; RNA, Ribosomal, 16S	2013
Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. Annals of the American Thoracic Society, 2014, Volume: 11, Issue:1 Topics: Administration, Inhalation; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Female; Humans; Kartagener Syndrome; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Pulmonary	2014
Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report. BMC pulmonary medicine, 2015, Oct-23, Volume: 15 Topics: Amikacin; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Clarithromycin; Ethambutol; Female; Humans; Immunocompromised Host; Lung; Middle Aged; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Rifampin; Tomography, X-Ray Computed	2015
Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease. Respirology (Carlton, Vic.), 2016, Volume: 21, Issue:2 Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Amikacin; Anti-Bacterial Agents; Female; Hearing Loss; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Treatment Outcome; Vestibular Diseases	2016
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. American journal of respiratory and critical care medicine, 2012, Sep-15, Volume: 186, Issue:6 Topics: Adult; Aged; Amikacin; Antibiotics, Antitubercular; Area Under Curve; Clarithromycin; Cohort Studies; Colorado; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Retrospective Studies; Rifabutin; Rifampin	2012
Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis. Acta paediatrica (Oslo, Norway : 1992), 2003, Volume: 92, Issue:8 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Child; Clarithromycin; Cohort Studies; Cystic Fibrosis; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Retrospective Studies; Rifampin; Streptomycin	2003
The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease. Chest, 2006, Volume: 130, Issue:4 Topics: Adult; Amikacin; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Lung; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Prednisone; Rifampin; Sputum; Tomography, X-Ray Computed	2006
Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series. BMC pulmonary medicine, 2007, Feb-23, Volume: 7 Topics: Administration, Inhalation; Administration, Oral; Aged; Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Lung Diseases; Macrolides; Middle Aged; Mycobacterium avium-intracellulare Infection; Treatment Outcome	2007
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:3 Topics: Amikacin; Animals; Clarithromycin; Drug Resistance, Microbial; Ethambutol; Female; Humans; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Spleen	1995
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:3 Topics: Amikacin; Clarithromycin; Drug Therapy, Combination; Humans; In Vitro Techniques; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection	1995
Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. The Journal of infectious diseases, 1994, Volume: 169, Issue:3 Topics: Amikacin; Animals; Azithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophages; Mice; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Recombinant Proteins	1994
Safety of rifabutin in a three-month-old infant. The Pediatric infectious disease journal, 1994, Volume: 13, Issue:2 Topics: Amikacin; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Isoniazid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pregnancy; Pregnancy Complications, Infectious; Rifabutin	1994
Lack of activities of amikacin and sulphamethoxazole against Mycobacterium avium-intracellulare. International journal of clinical pharmacology research, 1993, Volume: 13, Issue:2 Topics: Adult; Aged; Amikacin; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Saliva; Sulfamethoxazole; Trimethoprim, Sulfamethoxazole Drug Combination	1993
Efficacy of triple drug regimen of amikacin, ethambutol and rifabutin in AIDS patients with symptomatic Mycobacterium avium complex infection. The Journal of infection, 1993, Volume: 26, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amikacin; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin; Rifamycins	1993
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. International journal of STD & AIDS, 1996, Volume: 7, Issue:4 Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1996
Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:5 Topics: Amikacin; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Evaluation, Preclinical; Humans; Liposomes; Liver; Mice; Mice, Inbred C57BL; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Random Allocation; Spleen	1996
Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages. The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones; Rifabutin	1996
Paradoxical local response to therapy for Mycobacterium avium complex infection in four patients with AIDS. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Anti-Bacterial Agents; Clarithromycin; Hepatomegaly; Humans; Lymph Nodes; Male; Mycobacterium avium-intracellulare Infection	1998
Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium. FEMS immunology and medical microbiology, 1999, Volume: 23, Issue:1 Topics: AIDS-Related Opportunistic Infections; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiometry; Rifampin	1999
MAC management. PI perspective, 1996, Issue:No 20 Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Tuberculin Test; Zidovudine	1996
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Bacteremia; Cause of Death; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Pilot Projects	1992
Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. Archives of internal medicine, 1991, Volume: 151, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin	1991
Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides. The Journal of infectious diseases, 1990, Volume: 161, Issue:6 Topics: Amikacin; Animals; Disease Models, Animal; Drug Carriers; Female; Follow-Up Studies; Gentamicins; Liposomes; Liver; Mice; Mice, Inbred C57BL; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Organ Size; Spleen	1990
Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group. Annals of internal medicine, 1990, Sep-01, Volume: 113, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amikacin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Intravenous; Male; Mycobacterium avium-intracellulare Infection; Rifampin; Vomiting	1990
Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:2 Topics: Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Female; Imipenem; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Organ Size; Sepsis	1989
Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:8 Topics: Amikacin; Animals; Culture Media; Liposomes; Liver; Lung; Male; Mice; Mice, Inbred C57BL; Mycobacterium avium-intracellulare Infection; Spleen; Time Factors	1989